Format

Send to

Choose Destination
Am J Ophthalmol. 2014 May;157(5):1038-47. doi: 10.1016/j.ajo.2014.02.021. Epub 2014 Feb 14.

Chorioretinal folds: associated disorders and a related maculopathy.

Author information

1
Department of Ophthalmology, Emory University, Atlanta, Georgia. Electronic address: tolsen@emory.edu.
2
Department of Ophthalmology, Emory University, Atlanta, Georgia.

Abstract

PURPOSE:

To describe a series of chorioretinal folds (CRFs) representing a clinical sign that may be associated with multiple systemic, orbital, and ophthalmologic disorders. We report the associations with systemic disease and describe 3 stages of a CRF-related maculopathy.

DESIGN:

Observational, retrospective case series.

METHODS:

We reviewed 57 affected eyes from 40 patients with the clinical sign of CRF from 1 of 2 academic institutions. A careful review of the medical histories and systemic diagnostic evaluations were conducted. Imaging studies were conducted.

RESULTS:

The mean age at diagnosis was 64 ± 17 years. Most eyes (n = 18) were hyperopic (+2.60 ± +2.90 diopters). There were 20 patients (50%) with some form of autoimmune disorder. Overall, the mean presenting visual acuity was 20/50, declining slightly to 20/60 over 19 ± 30 months. Ten eyes had stage 3 CRF-related maculopathy, more common in older individuals with more chronic CRFs. Four stage 3 eyes had associated choroidal neovascularization, and these eyes had 20/60 presenting visual acuity that decreased to 20/100 over approximately 1.5 years. Stage 3 eyes without choroidal neovascularization had a mean presenting visual acuity of 20/40 that decreased to 20/65 over 2.1 years.

CONCLUSIONS:

CRFs are associated with numerous ophthalmic and systemic disorders. A careful medical history and evaluation are essential. We describe 3 stages of a unique CRF-related maculopathy. Stage 3 resembles occult choroidal neovascularization, occurs primarily in older individuals with chronic CRFs, and is accompanied by a slow deterioration in central acuity.

PMID:
24531022
DOI:
10.1016/j.ajo.2014.02.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center